Marino Stram & Associates’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $571K | Buy |
6,231
+20
| +0.3% | +$1.75K | 0.09% | 114 |
|
|
2026
Q1 | $529K | Buy |
6,211
+1
| +0% | +$89 | 0.1% | 111 |
|
|
2025
Q4 | $491K | Sell |
6,210
-90
| -1% | -$7.06K | 0.09% | 117 |
|
|
2025
Q3 | $504K | Buy |
6,300
+32
| +0.5% | +$2.73K | 0.09% | 122 |
|
|
2025
Q2 | $570K | Buy |
6,268
+17
| +0.3% | +$1.55K | 0.12% | 109 |
|
|
2025
Q1 | $586K | Buy |
6,251
+18
| +0.3% | +$1.61K | 0.13% | 106 |
|
|
2024
Q4 | $567K | Buy |
6,233
+16
| +0.3% | +$1.53K | 0.13% | 107 |
|
|
2024
Q3 | $645K | Buy |
6,217
+15
| +0.2% | +$1.53K | 0.14% | 102 |
|
|
2024
Q2 | $602K | Buy |
6,202
+11
| +0.2% | +$1.01K | 0.15% | 100 |
|
|
2024
Q1 | $558K | Hold |
6,191
| – | – | 0.13% | 105 |
|
|
2023
Q4 | $493K | Sell |
6,191
-262
| -4% | -$19.7K | 0.13% | 106 |
|
|
2023
Q3 | $459K | Buy |
6,453
+154
| +2% | +$11.5K | 0.13% | 105 |
|
|
2023
Q2 | $485K | Buy |
6,299
+181
| +3% | +$14K | 0.14% | 104 |
|
|
2023
Q1 | $460K | Buy |
6,118
+1
| +0% | +$74 | 0.14% | 103 |
|
|
2022
Q4 | $482K | Buy |
6,117
+2
| +0% | +$150 | 0.15% | 99 |
|
|
2022
Q3 | $430K | Buy |
6,115
+1
| +0% | +$78 | 0.16% | 94 |
|
|
2022
Q2 | $490K | Buy |
6,114
+1
| +0% | +$78 | 0.17% | 95 |
|
|
2022
Q1 | $464K | Buy |
6,113
+52
| +0.9% | +$4.12K | 0.15% | 104 |
|
|
2021
Q4 | $517K | Buy |
6,061
+164
| +3% | +$12.8K | 0.16% | 100 |
|
|
2021
Q3 | $446K | Buy |
5,897
+1,055
| +22% | +$83.8K | 0.15% | 100 |
|
|
2021
Q2 | $394K | Sell |
4,842
-835
| -15% | -$68.3K | 0.1% | 154 |
|
|
2021
Q1 | $448K | Buy |
5,677
+658
| +13% | +$51.6K | 0.18% | 87 |
|
|
2020
Q4 | $429K | Sell |
5,019
-28
| -0.6% | -$2.31K | 0.19% | 79 |
|
|
2020
Q3 | $389K | Buy |
5,047
+133
| +3% | +$10.1K | 0.21% | 73 |
|
|
2020
Q2 | $360K | Buy |
+4,914
| New | +$349K | 0.21% | 71 |
|
|
2019
Q2 | – | Sell |
-176
| Closed | -$12K | – | 161 |
|
|
2019
Q1 | $12K | Buy |
176
+16
| +10% | +$1.03K | 0.01% | 291 |
|
|
2018
Q4 | $10K | Hold |
160
| – | – | 0.01% | 274 |
|
|
2018
Q3 | $11K | Buy |
160
+1
| +0.6% | +$67 | 0.01% | 291 |
|
|
2018
Q2 | $10K | Buy |
159
+1
| +0.6% | +$65 | 0.01% | 298 |
|
|
2018
Q1 | $11K | Sell |
158
-5
| -3% | -$360 | 0.01% | 299 |
|
|
2017
Q4 | $12K | Buy |
+163
| New | +$11.9K | 0.01% | 292 |
|
Other funds holding CL
Marino Stram & Associates's CL Position: Q2 2026 in Review
Marino Stram & Associates increased its Colgate-Palmolive (CL) stake by 0.32% in Q2 2026, buying an estimated $1.75K and bringing the position to 6,231 shares worth $571K. The position accounts for 0.09% of the portfolio, ranked #114.
Marino Stram & Associates first reported a position in CL in Q4 2017 and has held it in 31 quarters since. The position peaked at $645K in Q3 2024. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Marino Stram & Associates held 6,231 shares of Colgate-Palmolive worth $571K as of Q2 2026.
- Marino Stram & Associates bought 20 Colgate-Palmolive shares in Q2 2026, an estimated $1.75K.
- Colgate-Palmolive made up 0.09% of Marino Stram & Associates's portfolio in Q2 2026, its #114 holding.
- Marino Stram & Associates first reported a position in Colgate-Palmolive in Q4 2017 and has held it in 31 quarters since.
- Marino Stram & Associates's Colgate-Palmolive position peaked at $645K in Q3 2024.
- 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Marino Stram & Associates's 13F filing for Q2 2026, filed 24 Jul 2026.